Will Gilead Beat 2Q Earnings? Perhaps…But Does It Matter?
July 21, 2017 at 13:38 PM EDT
When this biotech drug maker reports second quarter financial results on July 26, Guggenheim analyst Tony Butler expects earnings and revenue to beat expectations. But he also sees challenges ahead.
